Abbvie Inc (NYSE:ABBV) under-valued by 12%
| Website | https://www.abbvie.com/ |
| Sector | Healthcare |
| Industry | Drug Manufacturers General |
| Fiscal Year End | Dec 31, 2019 |
| Market Cap | $142,051,164,000 |
| Beta | 0.67286 |
| Average Volume | $7,198,578 |
| Last Dividend | 4.5% |
| Price on Aug 4, 2020 | $80.49 |
| Autochartist™ Valuation | $90.51 |
| Conclusion |
12% under-valued |
| Download Report |
